Phase 1Completed
Comparative Pharmacokinetic, Pharmacodynamic, and Safety Study of 1 Dose of Aspirin for Injection and Oral Aspirin Tablets in Healthy Adult Subjects
A Phase 1, Open-Label, 2-Period, 2-Formulation, Within-Subject Crossover Comparative Pharmacokinetic, Pharmacodynamic, and Safety Study of 1 Dose Level of Aspirin for Injection and Oral Aspirin Tablets in Healthy Adult Human Subjects Under Fasting Conditions.
- Sponsor
- Rhoshan Pharmaceuticals Inc (Industry)
- Enrolment
- 40 enrolled
- Conditions
- Healthy
- Interventions
- 325 mg Oral Aspirin; 325 mg aspirin by rapid IV push
- Ages
- adults
- Registry
- NCT07323680
Full record on ClinicalTrials.gov
From the registry
The purpose of this study is to compare the safety, pharmacokinetics, and pharmacodynamic effects of aspirin administered intravenously with aspirin administered orally.
Primary outcomes
- Change in serum thromboxane B2 from baseline
History
Last registry update
Registered
Study completion
Primary completion
Started